Impax Laboratories to Present at the Cowen & Company 33rd Annual Health Care
Cowen Group Healthcare Conference 2013
HAYWARD, Calif. -- March 1, 2013
Impax Laboratories, Inc. (NASDAQ: IPXL) today announced that the Company will
present at the Cowen & Company 33^rd Annual Health Care Conference on
Wednesday, March 6, at 8:00 a.m. Eastern Standard Time. The conference will be
held at The Boston Marriott Copley Place, Boston, MA.
Individuals may listen to the live or an archived presentation made at the
conference, which will be posted in the investor relations section of the
Company’s web site at www.impaxlabs.com. This presentation will be archived on
the Company’s web site for 30 days.
About Impax Laboratories, Inc.
Impax Laboratories, Inc. (Impax) is a technology based specialty
pharmaceutical company applying its formulation expertise and drug delivery
technology to the development of controlled-release and specialty generics in
addition to the development of central nervous system disorder branded
products. Impax markets its generic products through its Global
Pharmaceuticals division and markets its branded products through the Impax
Pharmaceuticals division. Additionally, where strategically appropriate, Impax
develops marketing partnerships to fully leverage its technology platform and
pursues partnership opportunities that offer alternative dosage form
technologies, such as injectables, nasal sprays, inhalers, patches, creams and
ointments. Impax Laboratories is headquartered in Hayward, California, and has
a full range of capabilities in its Hayward, Philadelphia and Taiwan
facilities. For more information, please visit the Company's Web site at:
Impax Laboratories, Inc.
Mark Donohue, 215-558-4526
Sr. Director, Investor Relations and Corporate Communications
Press spacebar to pause and continue. Press esc to stop.